3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
3
Breast Neoplasms
3
Weight Loss
2
Polyps
2
Hyperplasia
2
Stomach Neoplasms
1
Psoriasis
1
Osteoarthritis
1
Neoplasms
1
Muscular Atrophy
1
Muscle Weakness
1
Motor Activity
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Leukemia, Myeloid, Chronic-Phase
1
Colitis, Ulcerative
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Cancer Cachexia
1
Cachexia
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Anorexia
1
Adenomatous Polyps
1
Adenomatous Polyposis Coli
1
Interventions
tofacitinib
7
Etanercept
6
Methotrexate
3
Adalimumab
3
secukinumab
2
Nivolumab
2
sotrastaurin
1
sodium luminolate
1
ixekizumab
1
deucravacitinib
1
calcipotriene
1
cabozantinib
1
baricitinib
1
apremilast
1
abrocitinib
1
Vitamin D
1
Vaccines
1
Specimen Handling
1
Saline Solution
1
Platinum Compounds
1
Ipilimumab
1
Herpes Zoster Vaccine
1
Folic Acid
1
Fish Oils
1
Fatty Acids, Omega-3
1
Exercise
1
Eicosapentaenoic Acid
1
Docosahexaenoic Acids
1
Cholecalciferol
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Psoriasis
×
Eicosapentaenoic Acid
×
Clear all
NCT01351805
2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA
Completed
25,871 enrolled
15 charts